Target intelligence / Profile preview

RNA, U6 small nuclear 346, pseudogene (RNU6-346P)

Target: RNU6-346P
Molecular classification: Other: Pseudogene, Small nuclear RNA (snRNA) pseudogene (by homology to U6 snRNA family)

Overview

RNU6-346P (RNA, U6 small nuclear 346, pseudogene) is a human pseudogene homologous to U6 small nuclear RNA (snRNA), an abundant non-coding RNA component of the spliceosome. U6 snRNA is highly conserved and essential for pre-mRNA splicing, but this specific locus (346, pseudogene) does not produce functional RNA and is defined as a processed pseudogene[1][3][4]. Although rare pseudogenes can regulate gene expression through RNA interference or as miRNA sponges (competing endogenous RNA, ceRNA), there is no evidence that RNU6-346P functions in such a role[2]. Pseudogenes related to U6 snRNA occur commonly throughout vertebrate genomes, reflecting evolutionary duplication events rather than functional necessity[3][4]. RNU6-346P is not a protein, receptor, or enzyme, and thus not a classical molecular target or druggable entity. In summary: it is an inactive genetic locus, with no confirmed biological function, disease association, or drug interaction.

Other names: RNU6-346PRNA, U6 small nuclear 346, pseudogene

Biological functions

Other: Typically non-functional; may have minor regulatory activity by sequence similarity or through RNA-mediated ceRNA effects, but this is not established for RNU6-346P specifically[2].

Disease associations

Other: For most pseudogenes, disease association is rare. Some pseudogenes elsewhere in the genome have been implicated in cancer, but no direct role for RNU6-346P is documented[2].

Beyond the preview

Go deeper on RNA, U6 small nuclear 346, pseudogene (RNU6-346P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 346, pseudogene (RNU6-346P).

Explore the full profile